Prenatal exposures to medication affecting brain neurotransmitter systems and risk of ASD

(JAMA Network) An exploratory study that examined autism spectrum disorder (ASD) risk and prenatal exposure to medications that affect neurotransmitters, including the typical targets of antidepressants and antipsychotics, suggests that most medications weren't associated with higher estimates of ASD risk. The study used data from a large health maintenance organization in Israel for an analytic sample that included 34 groups of medications and 96,249 children, including 1,405 with ASD.

from EurekAlert! - Social and Behavioral Science https://www.eurekalert.org/pub_releases/2018-10/jn-pet102918.php